Akebia Therapeutics, Inc.
AKBA
Revenue
43.65M
▲11.04M▲33.86%
3 Months ChangeAssets
220.20M
▼-5.28M▼-2.34%
3 Months ChangeLiabilities
253.95M
▲1.22M▲0.4807%
3 Months ChangeFree Cash Flow
-17.54M
▲4.20M▲19.31%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-22
Form 8-K
ID: 0001517022-24-000070
2024-10-16
Form 8-K
ID: 0001517022-24-000067
2024-08-08
Form 10-Q
ID: 0001628280-24-035879
2024-08-08
Form 8-K
ID: 0001517022-24-000065
2024-07-11
Form 8-K
ID: 0001517022-24-000061
2024-06-24
Form 8-K
ID: 0001517022-24-000059
2024-06-10
Form 8-K
ID: 0001517022-24-000057
2024-05-09
Form 10-Q
ID: 0001628280-24-021945
2024-05-09
Form 8-K
ID: 0001517022-24-000050
2024-04-23
Form 8-K
ID: 0001517022-24-000035